All,
As promised on last week’s call, I offer a proposal for what we’re calling “closed generics.”
I wanted to turn the attention away from the binary question of “closed generics” or “no closed generics” and think about why some ROs may have applied for closed generics. If we can solve for these problems (e.g. create processes that
solve for folks’ concerns AND allow applicants to innovate), my guess is, the fight will fade. The examples are not based on real stories but are illustrative; other use cases could be imagined if we move away from only thinking of domain names as the end
product/commodity. We should encourage next round applicants to innovate and explore ideas – we didn’t get the Tesla by forcing everyone to build a Model T, the Model T was a starting point to improve upon.
i. The RO has to undergo extensive security and privacy testing – by controlling the entire space (including being its own Registrar), the applicant can guard against phishing, malware,
hijacking, etc.
ii. The domain name is not sold to the end-user. It’s the way the devices and dashboards communicate. It does not need a retail chain or any Rr markup or fees for the applicant
to create the names it needs to run its product. The domain is just an easy handle for mobile and desktop access to the dashboard. It performs a function and is not a consumer product or service itself.
Some of you will argue that ALL medical device manufacturers should then have access to .heart, but that’s unrealistic since the medical device company that controls .heart will own all of the security and no other medical device company
would be willing to trust their competitors with their data and security.
Some of you will ask:
a.
“Why not just make it a .brand”? For a registry that is working on a standard for communication and security in this space, they will want it to be more “open” versus branded. That doesn’t mean just anyone can obtain. The registry
may need flexibility to monitor across a number of entities. Also, startups may not have a brand yet, or part of the new product/service may be creating a new brand.
b.
“But why not a community? Because some startups may be trying to disrupt an entrenched industry and you may not be able to get the large industry trade associations to back you and instead try to prevent change or innovation, as we
saw in the last round. We want to encourage innovation and new models. We don’t want to be ourselves an entrenched industry that is unwilling to embrace change.
i. Suggestion: create an option for an RO to decide domains in its TLD will be part of a bigger product or service and so long as the domain is bundled, the TLD can be owned and
operated by the RO.
i. Suggestion: make it easier for an Approved Launch Program or a new (TBD) Beta Program to include a multi-year beta.
ii. Suggestion: include some guardrails or “PIC” language to ensure that when the idea is launched to customers, Spec 9 will apply at that point.
As we can see, there is little point in assuming why ROs applied for closed generics - there were very likely business cases and innovative ideas behind the last round applications. These scenarios demonstrate that it is not difficult
to imagine business cases that could benefit from innovation – nor is it difficult to fashion solutions to address concerns that some may have about using TLDs in this way. Instead of being stuck in the binary yes/no deliberations of 8 years ago and failing
to meet the Board’s expectation that we will come back to them with a sensible policy recommendation, let’s instead build the guardrails that will allow innovation to proceed.
Thanks,
Kristine Dorrain